Saxton C A, Faulkner J K, Groom G V
Eur J Clin Pharmacol. 1981;21(2):103-8. doi: 10.1007/BF00637509.
In a placebo controlled double-blind study in six healthy male volunteers the effects of single oral doses of 100 mg and 200 mg of tolamolol on plasma concentrations of prolactin, growth hormone and luteinising hormone were investigated. In a second placebo controlled single-blind study in a further six healthy male volunteers the effects of single oral doses of 200 mg tolamolol and 160 mg propranolol on the same plasma hormone concentrations were compared. A dose dependent increase in plasma prolactin concentration was demonstrated after tolamolol. The increase in plasma prolactin concentration was not evident after propranolol. Plasma growth hormone and luteinising hormone concentrations were not significantly changed by either propranolol or tolamolol.
在一项针对6名健康男性志愿者的安慰剂对照双盲研究中,研究了单次口服100毫克和200毫克托拉洛尔对催乳素、生长激素和黄体生成素血浆浓度的影响。在另一项针对另外6名健康男性志愿者的安慰剂对照单盲研究中,比较了单次口服200毫克托拉洛尔和160毫克普萘洛尔对相同血浆激素浓度的影响。托拉洛尔给药后,血浆催乳素浓度呈剂量依赖性增加。普萘洛尔给药后,血浆催乳素浓度升高不明显。普萘洛尔或托拉洛尔均未显著改变血浆生长激素和黄体生成素浓度。